Clinical Trial Matching

Selected news for the healthcare topic - Clinical Trial Matching, collected since 1/2018. This healthcare topic shares news with Anderson, Indiana, IBM Watson, Precision Medicine and many others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics
Companies
Health Systems
Locations

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/9/2021 Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER Into Practice, Expanding Offering to Patients | Financial Buzz financialbuzz.com Beverly Hills Cancer Center and Deep Lens today announced a strategic collaboration that will deploy Deep Lens’ AI-based clinical trial matching solution VIPER™ and other services into one of Southern California’s few private cancer centers. VIPER uses proprietary cloud-based technology to identify and match oncology patients to trials for which they may be eligible right at the time of diagnosis. As part of this partnership ...
9/9/2021 Beverly Hills Cancer Center and Deep Lens Partner to Integrate Novel AI-based Clinical Trial Matching Solution VIPER™ Into Practice, Expanding Offering to Patients Business Wire COLUMBUS, Ohio & LOS ANGELES--(BUSINESS WIRE)--Sep 9, 2021-- Beverly Hills Cancer Center and Deep Lens today announced a strategic collaboration that will deploy Deep Lens’ AI-based clinical trial matching solution VIPER™ and other services into one of Southern California’s few private cancer centers. VIPER uses proprietary cloud-based technology to identify and match oncology patients to trials for which they may be eligible right at ...
8/31/2021 Massive Bio, Inc. to Partner With Veterans Prostate Cancer Awareness and Self-Care Catalysts to Accelerate Clinical Trial Enrollment and Digital Health Solutions Business Wire ... guide thousands of Veterans to new treatments and clinical trials,” stated Mike “Bing” Crosby, Founder & CEO of VPCa. Massive Bio is known in the healthcare industry for its SYNERGY-Artificial Intelligence (AI) clinical trial matching program, as well as its Virtual Tumor Board. Massive Bio is a leader in AI-enabled patient-centric clinical trial enrollment whose mission is to provide cancer patients access to clinical trials regardless ...
8/31/2021 Massive Bio teams up with veterans nonprofit to increase prostate cancer research, trial enrollment | FierceBiotech FierceBiotech ... phase 1/2 trials are in progress for prostate cancer treatment, the Prostate Cancer Foundation estimates.RELATED: Massive Bio, IBM Watson, others team up with Biden Cancer Initiative for oncology workThrough its artificial intelligence clinical trial matching program, Massive Bio aims to enroll cancer patients into trials regardless of location or financial situation, the company said. The program includes patient identification and prescreening outside the trial site along with registration ...
8/31/2021 Massive Bio, Inc. to Partner With Veterans Prostate Cancer Awareness and Self-Care Catalysts to Accelerate Clinical Trial Enrollment and Digital Health Solutions itbusinessnet.com ... guide thousands of Veterans to new treatments and clinical trials,” stated Mike “Bing” Crosby, Founder & CEO of VPCa. Massive Bio is known in the healthcare industry for its SYNERGY-Artificial Intelligence (AI) clinical trial matching program, as well as its Virtual Tumor Board. Massive Bio is a leader in AI-enabled patient-centric clinical trial enrollment whose mission is to provide cancer patients access to clinical trials regardless ...
8/20/2021 gocli 0.9.15 pypi.org ... the GO KMS via REST API calls for the following functionality: - Variant HGVS Calculation (g., p., c.) - Variant Annotation (e.g. gnomAD, dbSNP, etc.) - Variant Classification (e.g. ACGM or AMP Tiers) - Gene and Protein Information - Clinical Trial Matching - Therapeutic Matching - Variant Warehouse Loading and Querying High Performance “High performance” is achieved through functional programming that minimizes memory consumption and asynchronous programming style (async/await, asyncio) that maximizes concurrency in high ...
8/17/2021 Tempus Submits PMA Application to the Its xT-Onco Assay Business Wire ... submission builds on Tempus’ existing precision medicine platform, adding the regulatory component to provide a comprehensive suite of solutions for novel drug development programs. Sponsors can leverage Tempus’ next-generation sequencing platform, clinical trial matching capabilities and its vast library of clinical and molecular data to support therapeutic innovation. The combination of these components, along with Tempus’ advanced artificial intelligence capabilities, distinguishes Tempus’ unique approach to ...
8/17/2021 Tempus Submits PMA Application to the FDA for Its xT-Onco Assay | Financial Buzz financialbuzz.com ... submission builds on Tempus’ existing precision medicine platform, adding the regulatory component to provide a comprehensive suite of solutions for novel drug development programs. Sponsors can leverage Tempus’ next-generation sequencing platform, clinical trial matching capabilities and its vast library of clinical and molecular data to support therapeutic innovation. The combination of these components, along with Tempus’ advanced artificial intelligence capabilities, distinguishes Tempus’ unique approach to ...
7/26/2021 Central Care Cancer Center and Deep Lens Partner to Integrate AI-Matching Solution, VIPER™, Into Network, Expanding Clinical Research Program healthtechhotspot.com COLUMBUS, Ohio & SALINA, Kansas–(BUSINESS WIRE)– clinicalresearch — Central Care Cancer Center and Deep Lens today announced a strategic partnership that will deploy Deep Lens’ novel clinical trial matching solution, VIPER™, into the 10-location Kansas and Missouri-based oncology practice network. To help overcome challenges related to oncology clinical trial enrollment, VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial ...
7/23/2021 Central Care Cancer Center and Deep Lens Partner to Integrate AI-Matching Solution, VIPER™, Into Network, Expanding Clinical Research Program Yahoo News COLUMBUS, Ohio & SALINA, Kansas, July 23, 2021 --( BUSINESS WIRE )-- Central Care Cancer Center and Deep Lens today announced a strategic partnership that will deploy Deep Lens’ novel clinical trial matching solution, VIPER™, into the 10-location Kansas and Missouri-based oncology practice network. To help overcome challenges related to oncology clinical trial enrollment, VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment ...
7/23/2021 Central Care Cancer Center and Deep Lens Partner to Integrate AI-Matching Solution, VIPER™, Into Network, Expanding Clinical Research Program virtual-strategy.com COLUMBUS, Ohio & SALINA, Kansas–( BUSINESS WIRE )– Central Care Cancer Center and Deep Lens today announced a strategic partnership that will deploy Deep Lens’ novel clinical trial matching solution, VIPER™, into the 10-location Kansas and Missouri-based oncology practice network. To help overcome challenges related to oncology clinical trial enrollment, VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process ...
7/23/2021 Central Care Cancer Center and Deep Lens Partner to Integrate AI-Matching Solution, VIPER™, Into Network, Expanding Clinical Research Program Business Wire COLUMBUS, Ohio & SALINA, Kansas--(BUSINESS WIRE)--Jul 23, 2021-- Central Care Cancer Center and Deep Lens today announced a strategic partnership that will deploy Deep Lens’ novel clinical trial matching solution, VIPER™, into the 10-location Kansas and Missouri-based oncology practice network. To help overcome challenges related to oncology clinical trial enrollment, VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment ...
7/23/2021 Central Care Cancer Center and Deep Lens Partner to Integrate AI-Matching Solution, VIPER™, Into Network, Expanding Clinical Research Program mytechdecisions.com COLUMBUS, Ohio & SALINA, Kansas–(BUSINESS WIRE)– clinicalresearch — Central Care Cancer Center and Deep Lens today announced a strategic partnership that will deploy Deep Lens’ novel clinical trial matching solution, VIPER™, into the 10-location Kansas and Missouri-based oncology practice network. To help overcome challenges related to oncology clinical trial enrollment, VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial ...
7/21/2021 Guys’ and St Thomas’ to take part in AI cancer trials digitalhealth.net ... intelligent automation afforded by Trial Navigator will prove to be an effective solution for identifying greater numbers of our eligible cancer patient population for clinical trials.” Trial Navigator has been designed to improve clinical trial matching and supports both the clinician at the point of care and trial coordinators. The software can also be used to carry out instantaneous lookups against relevant trial databases. Oenone Duroe, general manager for ...
7/7/2021 Cancer and Blood Specialty Clinic Adopts Deep Lens Clinical Trial Matching Solution VIPER to Broaden Clinical Research Program | Financial Buzz financialbuzz.com The Cancer and Blood Specialty Clinic (CBSC) and Deep Lens announced today that they have entered into a strategic partnership to integrate artificial intelligence (AI)-based clinical trial matching solution, VIPER‚Ñ¢, into the Southern California-based practice. VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process. The CBSC serves cancer patients across four locations in Southern California. This collaboration will allow CBSC ...
7/7/2021 Cancer and Blood Specialty Clinic Adopts Deep Lens’ Clinical Trial Matching Solution VIPER™ to Broaden Clinical Research Program Yahoo News COLUMBUS, Ohio & LOS ALAMITOS, Calif., July 07, 2021 --( BUSINESS WIRE )--The Cancer and Blood Specialty Clinic (CBSC) and Deep Lens announced today that they have entered into a strategic partnership to integrate artificial intelligence (AI)-based clinical trial matching solution, VIPER™, into the Southern California-based practice. VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process. The CBSC serves cancer patients across ...
7/7/2021 MBN Media mbn.media COLUMBUS, Ohio & LOS ALAMITOS, Calif.–( BUSINESS WIRE )–The Cancer and Blood Specialty Clinic (CBSC) and Deep Lens announced today that they have entered into a strategic partnership to integrate artificial intelligence (AI)-based clinical trial matching solution, VIPER(TM), into the Southern California-based practice. VIPER uses proprietary, cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process. The CBSC serves cancer patients across four locations ...
6/29/2021 Dayton Physicians Network Adopts Deep Lens' Novel Clinical Trial Matching Solution, VIPERâ„¢, Broadening Research Program and Offering to Patients tmcnet.com TMCnet News [June 29, 2021] Dayton Physicians Network Adopts Deep Lens' Novel Clinical Trial Matching Solution, VIPER™, Broadening Research Program and Offering to Patients Dayton Physicians Network and Deep Lens today announced that they have partnered to integrate artificial intelligence (AI)-based clinical trial matching solution, VIPER™, into their network, expanding their research program and the oncology trial offering to patients. Dayton Physicians Network was one of the ...
5/19/2021 malvern-online.com Deep Lens and New England Cancer Specialists (NECS) today announced that they have entered into a strategic collaboration to deploy artificial-intelligence (AI)-based clinical trial matching solution, VIPER™, into the NECS network. The Deep Lens’ VIPER platform uses proprietary cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process. NECS is the region’s largest medical oncology group and serves patients in five locations ...
5/19/2021 The Ridgway Record ridgwayrecord.com Deep Lens and New England Cancer Specialists (NECS) today announced that they have entered into a strategic collaboration to deploy artificial-intelligence (AI)-based clinical trial matching solution, VIPER™, into the NECS network. The Deep Lens’ VIPER platform uses proprietary cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process. NECS is the region’s largest medical oncology group and serves patients in five locations ...